tiprankstipranks
AN2 Therapeutics reports Q2 EPS (48c), consensus (59c)
PremiumThe FlyAN2 Therapeutics reports Q2 EPS (48c), consensus (59c)
3M ago
Morning Movers: Iteris skyrockets following take-private agreement
Premium
The Fly
Morning Movers: Iteris skyrockets following take-private agreement
4M ago
AN2 Therapeutics downgraded to Underperform from In Line at Evercore ISI
Premium
The Fly
AN2 Therapeutics downgraded to Underperform from In Line at Evercore ISI
4M ago
Intuit initiated, Charter downgraded: Wall Street’s top analyst calls
PremiumThe FlyIntuit initiated, Charter downgraded: Wall Street’s top analyst calls
5M ago
AN2 Therapeutics price target lowered to $2 from $7 at Evercore ISI
Premium
The Fly
AN2 Therapeutics price target lowered to $2 from $7 at Evercore ISI
6M ago
AN2 Therapeutics reports Q1 EPS (56c), consensus (62c)
Premium
The Fly
AN2 Therapeutics reports Q1 EPS (56c), consensus (62c)
6M ago
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
PremiumThe FlyCantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
9M ago
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
Premium
The Fly
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
9M ago
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
Premium
The Fly
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100